pharmaceuticals-and-healthcare

United States Osteoarthritis Pain Drugs Market Report 2017


Published On : Jan 2017

Category : Arthritis

No. of Pages : 117 pages

  • $3800
  • $7600

Please click below to avail discount on this report

Notes:
Sales, means the sales volume of Osteoarthritis Pain Drugs
Revenue, means the sales value of Osteoarthritis Pain Drugs

This report studies sales (consumption) of Osteoarthritis Pain Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Laboratories
Johnson & Johnson
Novartis
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
CrystalGenomics
Cytori Therapeutics
Daiichi Sankyo
Eli Lilly
Endo Pharmaceuticals Holdings
Horizon Pharma, iCeutica
Iroko Pharmaceuticals
Merck, Nuvo Research
Regeneron Pharmaceuticals
Sanofi, SantoSolve
Techfields Pharma
Winston Pharmaceuticals
Yooyoung Pharmaceutical
Zynerba Pharmaceuticals

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Oral
Injection
External Use
Split by applications, this report focuses on sales, market share and growth rate of Osteoarthritis Pain Drugs in each application, can be divided into
Hospital
Clinic

Arthritis is referred to a disorder that impacts the joints present in the body. The symptoms generally comprise stiffness and joint pain. The affected joints may experience warmth, swelling, redness, and reduced motion. In different forms of arthritis, other organs are also affected. The most common types of arthritis are rheumatoid arthritis and osteoarthritis. The treatment for arthritis may include physical therapy, medications, surgery, and alternative medicine. The arthritis industry is rather large consisting of equipment, medicines, and other products to be used. With the growing geriatric population and rising number of people suffering from arthritis, the industry is expected to have a bright future.

The research study offers an exclusive rundown of the factors that are likely to have a lasting or short term impact on the growth of the United states osteoarthritis pain drugs market report 2017 market during the forecast period. The report perfectly explores elements that are likely to have a stimulus or delayed effect on the United states osteoarthritis pain drugs market report 2017 market in the short or long run. The growth trajectory of the market has also been minutely studied with special attention on the drivers, restraints, and prospects present in the United states osteoarthritis pain drugs market report 2017 market for the players and investors to look on to. Several facets such as inflow of raw materials and outflow of end products, imports and exports, policies and regulations of governments, performance of the market in the global and regional level, products distributed and sold, and industrialized capacity of the industrial unit have also been emphasized upon in the study.

Varied regions where the market is set-up have also been paid attention to and the elements at play assisting or hindering the expansion of the market in those regions. The report also provides an inclusive outlook of the elite companies operating in the United states osteoarthritis pain drugs market report 2017 market. With the help of this, the reader can have a clear picture of the competitive landscape of the players and a comprehension of the products and marketing tactics of the leading players in the United states osteoarthritis pain drugs market report 2017 market. 

Table of Contents

United States Osteoarthritis Pain Drugs Market Report 2017
1 Osteoarthritis Pain Drugs Overview
1.1 Product Overview and Scope of Osteoarthritis Pain Drugs
1.2 Classification of Osteoarthritis Pain Drugs
1.2.1 Oral
1.2.2 Injection
1.2.3 External Use
1.3 Application of Osteoarthritis Pain Drugs
1.3.1 Hospital
1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Osteoarthritis Pain Drugs (2011-2021)
1.4.1 United States Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)

2 United States Osteoarthritis Pain Drugs Competition by Manufacturers
2.1 United States Osteoarthritis Pain Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Osteoarthritis Pain Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Osteoarthritis Pain Drugs Average Price by Manufactures (2015 and 2016)
2.4 Osteoarthritis Pain Drugs Market Competitive Situation and Trends
2.4.1 Osteoarthritis Pain Drugs Market Concentration Rate
2.4.2 Osteoarthritis Pain Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Osteoarthritis Pain Drugs Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Osteoarthritis Pain Drugs Sales and Market Share by States (2011-2016)
3.2 United States Osteoarthritis Pain Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Osteoarthritis Pain Drugs Price by States (2011-2016)

4 United States Osteoarthritis Pain Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Osteoarthritis Pain Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Osteoarthritis Pain Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Osteoarthritis Pain Drugs Price by Type (2011-2016)
4.4 United States Osteoarthritis Pain Drugs Sales Growth Rate by Type (2011-2016)

5 United States Osteoarthritis Pain Drugs Sales (Volume) by Application (2011-2016)
5.1 United States Osteoarthritis Pain Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Osteoarthritis Pain Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 United States Osteoarthritis Pain Drugs Manufacturers Profiles/Analysis
6.1 Abbott Laboratories
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.1.2.1 Oral
6.1.2.2 Injection
6.1.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
6.2.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.2.2.1 Oral
6.2.2.2 Injection
6.2.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Novartis
6.3.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.3.2.1 Oral
6.3.2.2 Injection
6.3.3 Novartis Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.4.2.1 Oral
6.4.2.2 Injection
6.4.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 AbbVie
6.5.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.5.2.1 Oral
6.5.2.2 Injection
6.5.3 AbbVie Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
6.6 Abiogen Pharma
6.6.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.6.2.1 Oral
6.6.2.2 Injection
6.6.3 Abiogen Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.6.4 Main Business/Business Overview
6.7 Afferent Pharmaceuticals
6.7.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.7.2.1 Oral
6.7.2.2 Injection
6.7.3 Afferent Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.7.4 Main Business/Business Overview
6.8 Astellas Pharma
6.8.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.8.2.1 Oral
6.8.2.2 Injection
6.8.3 Astellas Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.8.4 Main Business/Business Overview
6.9 BioDelivery Sciences International
6.9.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.9.2.1 Oral
6.9.2.2 Injection
6.9.3 BioDelivery Sciences International Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.9.4 Main Business/Business Overview
6.10 CrystalGenomics
6.10.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
6.10.2.1 Oral
6.10.2.2 Injection
6.10.3 CrystalGenomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.10.4 Main Business/Business Overview
6.11 Cytori Therapeutics
6.12 Daiichi Sankyo
6.13 Eli Lilly
6.14 Endo Pharmaceuticals Holdings
6.15 Horizon Pharma, iCeutica
6.16 Iroko Pharmaceuticals
6.17 Merck, Nuvo Research
6.18 Regeneron Pharmaceuticals
6.19 Sanofi, SantoSolve
6.20 Techfields Pharma
6.21 Winston Pharmaceuticals
6.22 Yooyoung Pharmaceutical
6.23 Zynerba Pharmaceuticals

7 Osteoarthritis Pain Drugs Manufacturing Cost Analysis
7.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Osteoarthritis Pain Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Osteoarthritis Pain Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Osteoarthritis Pain Drugs Market Forecast (2016-2021)
11.1 United States Osteoarthritis Pain Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Osteoarthritis Pain Drugs Sales Forecast by Type (2016-2021)
11.3 United States Osteoarthritis Pain Drugs Sales Forecast by Application (2016-2021)
11.4 Osteoarthritis Pain Drugs Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Osteoarthritis Pain Drugs
Table Classification of Osteoarthritis Pain Drugs
Figure United States Sales Market Share of Osteoarthritis Pain Drugs by Type in 2015
Figure Oral Picture
Figure Injection Picture
Figure External Use Picture
Table Application of Osteoarthritis Pain Drugs
Figure United States Sales Market Share of Osteoarthritis Pain Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2021)
Figure United States Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Table United States Osteoarthritis Pain Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Osteoarthritis Pain Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Osteoarthritis Pain Drugs Sales Share by Manufacturers
Figure 2016 Osteoarthritis Pain Drugs Sales Share by Manufacturers
Table United States Osteoarthritis Pain Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Osteoarthritis Pain Drugs Revenue Share by Manufacturers
Table 2016 United States Osteoarthritis Pain Drugs Revenue Share by Manufacturers
Table United States Market Osteoarthritis Pain Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Osteoarthritis Pain Drugs Average Price of Key Manufacturers in 2015
Figure Osteoarthritis Pain Drugs Market Share of Top 3 Manufacturers
Figure Osteoarthritis Pain Drugs Market Share of Top 5 Manufacturers
Table United States Osteoarthritis Pain Drugs Sales by States (2011-2016)
Table United States Osteoarthritis Pain Drugs Sales Share by States (2011-2016)
Figure United States Osteoarthritis Pain Drugs Sales Market Share by States in 2015
Table United States Osteoarthritis Pain Drugs Revenue and Market Share by States (2011-2016)
Table United States Osteoarthritis Pain Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Osteoarthritis Pain Drugs by States (2011-2016)
Table United States Osteoarthritis Pain Drugs Price by States (2011-2016)
Table United States Osteoarthritis Pain Drugs Sales by Type (2011-2016)
Table United States Osteoarthritis Pain Drugs Sales Share by Type (2011-2016)
Figure United States Osteoarthritis Pain Drugs Sales Market Share by Type in 2015
Table United States Osteoarthritis Pain Drugs Revenue and Market Share by Type (2011-2016)
Table United States Osteoarthritis Pain Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Osteoarthritis Pain Drugs by Type (2011-2016)
Table United States Osteoarthritis Pain Drugs Price by Type (2011-2016)
Figure United States Osteoarthritis Pain Drugs Sales Growth Rate by Type (2011-2016)
Table United States Osteoarthritis Pain Drugs Sales by Application (2011-2016)
Table United States Osteoarthritis Pain Drugs Sales Market Share by Application (2011-2016)
Figure United States Osteoarthritis Pain Drugs Sales Market Share by Application in 2015
Table United States Osteoarthritis Pain Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Osteoarthritis Pain Drugs Sales Growth Rate by Application (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abiogen Pharma Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Afferent Pharmaceuticals Basic Information List
Table Afferent Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Afferent Pharmaceuticals Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table BioDelivery Sciences International Basic Information List
Table BioDelivery Sciences International Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioDelivery Sciences International Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table CrystalGenomics Basic Information List
Table CrystalGenomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table CrystalGenomics Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Cytori Therapeutics Basic Information List
Table Daiichi Sankyo Basic Information List
Table Eli Lilly Basic Information List
Table Endo Pharmaceuticals Holdings Basic Information List
Table Horizon Pharma, iCeutica Basic Information List
Table Iroko Pharmaceuticals Basic Information List
Table Merck, Nuvo Research Basic Information List
Table Regeneron Pharmaceuticals Basic Information List
Table Sanofi, SantoSolve Basic Information List
Table Techfields Pharma Basic Information List
Table Winston Pharmaceuticals Basic Information List
Table Yooyoung Pharmaceutical Basic Information List
Table Zynerba Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Osteoarthritis Pain Drugs
Figure Manufacturing Process Analysis of Osteoarthritis Pain Drugs
Figure Osteoarthritis Pain Drugs Industrial Chain Analysis
Table Raw Materials Sources of Osteoarthritis Pain Drugs Major Manufacturers in 2015
Table Major Buyers of Osteoarthritis Pain Drugs
Table Distributors/Traders List
Figure United States Osteoarthritis Pain Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Osteoarthritis Pain Drugs Production Forecast by Type (2016-2021)
Table United States Osteoarthritis Pain Drugs Consumption Forecast by Application (2016-2021)
Table United States Osteoarthritis Pain Drugs Sales Forecast by States (2016-2021)
Table United States Osteoarthritis Pain Drugs Sales Share Forecast by States (2016-2021)

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top